A Sequencing Platform
Next-generation sequencing (NGS) technologies have revolutionized genomic research over the last decade. With today’s advanced NGS protocols and sequencing instruments, it has become economically feasible to simultaneously sequence billions of DNA or RNA fragments from a single sample. NGS assays enable comprehensive studies of genome and transcriptome function at an unprecedented depth and level of detail. This disruptive technology helped turning biology into a quantitative science and readily generates big data amenable to innovative artificial intelligence approaches.
The Biomedical Sequencing Facility (BSF) is Austria’s first dedicated technology platform for next-generation sequencing in biomedicine. As such, it is positioned to play a catalysing role in advancing genomic medicine in the country. The BSF offers cutting-edge sequencing technology, expert bioinformatics services, and facilitates access to post-genomic tools for both life science researchers and clinical scientists. In addition, the BSF contributes to several flagship research initiatives that aim to establish proofs-of-concept for genomic medicine in Austria.
The BSF is run by a dedicated team of staff scientists holding master or PhD degrees in life sciences.
